Nanjing Vazyme Biotech Co., Ltd. (688105.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 6.53B |
| Enterprise Value | 6.54B |
| P/E Ratio | 1,432.1 |
| PEG Ratio | 5.76 |
| Price/Sales Ratio | 7.71 |
| Price/Book Ratio | 3.31 |
| Enterprise/Revenue | 8.07 |
| Enterprise/EBITDA | 318.12 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | -0.02 |
| Return On Assets | 0 |
| Return On Equity | 0 |
| Revenue | 1.38B |
| Revenue/Share | 3.01 |
| Gross Profit | -40.48M |
| EBITDA | 165.62M |
| Net Income | -16.97M |
| Diluted EPS | -0.04 |
| Total Cash | 2.79B |
| Total Cash/Share | 5.4 |
| Total Debt | 856.9M |
| Total Debt/Equity | 0.24 |
| Current Ratio | 3.36 |
| Book Value Per Share | 7.04 |
| 52-Week Change | 27.4 |
| 52-Week High | 29.16 |
| 52-Week Low | 12.89 |
| Moving Average 50 Days | 23.1 |
| Moving Average 200 Days | 18.29 |
| Average Volume | 14.53M |
| Shares Outstanding | 516.99M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 2.16 |
| Payout Ratio | 335.14 |
| Last Split Factor | 13:10 |
| Last Split Date | June 03, 2026 |